title: Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults).
abstract: Grippovac SE-AZh a polytype, subunit influenza virus vaccine containing H1N1 and H3N2 influenza A virus strains and one influenza B virus strain has been tested in 80 volunteers. The trials demonstrated the harmlessness, the absence of adverse reactions, and except of the B type, the high antigenicity of vaccine preparation when administered in two injections. The optimal dose of each viral strain haemagglutinin (HA) was 15 micrograms in 0.5 ml.
authors.forename: L G
authors.initials: LG
authors.lastname: Rudenko
authors.forename: M P
authors.initials: MP
authors.lastname: Zykov
authors.lastname: Romanov YuA
authors.forename: N G
authors.initials: NG
authors.lastname: Zakharov
authors.forename: V M
authors.initials: VM
authors.lastname: Leonov
authors.forename: S K
authors.initials: SK
authors.lastname: Melnikova
authors.forename: M P
authors.initials: MP
authors.lastname: Chumakov
mesh_terms: D000328:Adult; D000956:Antigens, Viral / Q000032:analysis; D005334:Fever / Q000209:etiology; D006801:Humans; D007109:Immunity; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D014611:Vaccination
chemical_list: D000956:Antigens, Viral; D007252:Influenza Vaccines